MOv18 IgE
Phase 1- Indications
- Ovarian cancer, Advanced solid tumors
Company intelligence / Profile preview
ALSA Ventures
London, England, United Kingdomalsaventures.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Phase 1
01
Overview
ALSA Ventures is a London-based life science venture capital firm established in 2019. It invests in early-stage European biotech companies developing novel therapeutics across modalities and indications. The fund supports portfolio companies from late preclinical through early clinical stages and has launched initiatives like the Eclipse accelerator for advancing assets into first-in-human studies. Notable investments include Epsilogen Ltd., Oxford Biotherapeutics, Montis Biosciences, Axovia Therapeutics, Vantage Biosciences, Promatix, among others. Clinical results are not directly reported by ALSA as it is an investment firm.
- Therapeutic areas
- OncologyImmunologyRare DiseasesOphthalmologyWomen's Health
- Modalities
- Small moleculeMonoclonal antibodyGene therapyBiologic
- Industry
- Investors
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Lonza (manufacturing/development support for portfolio companies)ICON plc (CRO partner for Eclipse accelerator program)
Beyond the preview
Go deeper on ALSA Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALSA Ventures.